Regeneration and Repair at Scale

BioDaVinci leverages a novel application of the most proven drug modality in history: small molecules.

Our AI platform maps bioelectric signaling (the software-like command layer of cells) to identify drugs that actively instruct regeneration and repair.

Through drug arbitrage, we identify safe chemistry that failed past clinical trials due to an indication mismatch.

Applying this de-risked chemistry to modulation of bioelectric signaling transforms stranded assets into rescue candidates and provides the foundation for novel optimizations. 

The result is BioDaVinci’s pipeline of first-in-class regenerative therapeutics